5 results match your criteria: "The Swiss Federal Institute of Technology (ETH Zurich)[Affiliation]"

Article Synopsis
  • Alzheimer's disease (AD) is primarily a sporadic condition largely linked to the APOE ε4 gene, with limited disease-modifying treatments available, mainly aducanumab and lecanemab.
  • Attention-deficit hyperactivity disorder (ADHD) is common in children and persists into adulthood for many, with its treatment relying on first-line stimulants like methylphenidate (MPH) but lacking definitive disease-modifying therapies.
  • Research suggests potential links between ADHD and AD, including shared cognitive deficits and biological pathways, indicating that ADHD might increase the risk for developing AD and that treatments for ADHD might benefit cognitive function in early stages of dementia.
View Article and Find Full Text PDF

Psychological Antecedents of Retirement Planning: A Systematic Review.

Front Psychol

October 2018

Department of Management, Technology, and Economics, The Swiss Federal Institute of Technology (ETH-Zürich), Zurich, Switzerland.

As workforce aging continues through the next decade, the number of persons who will retire from long-held jobs and careers will increase. In recent years, researchers across disciplines of psychology have focused attention on the impact of the retirement process on post-retirement adjustment and well-being. The objective of the current review is twofold.

View Article and Find Full Text PDF
Article Synopsis
  • Systems biology sees biological functions as emerging from the interactions within dynamic networks of elements, particularly focusing on protein complexes and their arrangement within cells.
  • 'Visual proteomics' aims to map these complexes inside living cells using techniques like cryo-electron tomography and quantitative mass spectrometry.
  • The study introduces a scoring function for assessing visual proteomics, evaluates its accuracy, and discusses the limitations and future enhancements of this approach.
View Article and Find Full Text PDF

The Federal Circuit uses particular patent doctrines as policy levers to control the nature of the nation's patent output. Most recently, the court has looked to the narrow implementation of the written description doctrine to limit the scope of biotechnology patents in general and DNA patents in particular. Recent case-law now indicates a slow evolution within the Federal Circuit to loosen this control and broaden the scope of DNA patents.

View Article and Find Full Text PDF